What is a slow cognitive pace?

Sluggish Cognitive Tempo (SCT) refers to a cluster of symptoms such as drowsiness, low energy, dreaming and confusion that sometimes affects people with primarily inattentive forms of disorder of attention hyperactivity (ADHD-PI). The cause of SCT is theorized as dysregulation of norepinephrine and other neurotransmitters, leading to too small brain stimulation. The topic of SCT evoked a large number of comments. First, the symptoms are not found in diagnostic and statistical manuals of 2000 IV ® ( dsm-IV ®), causing diagnosis problems. Some experts also claim that SCT is either a reliable subgroup of ADHD or a completely different disorder. These symptoms of slow cognitive tempo seem to automatically indicate ADHD. The missing element of the condition, from a diagnostic point of view, is the overall high energy or ghost, which almost always occur in patients with ADHD. It is not clear why it is missing, and some claimed that SCT is similar to conditions such as the main depression or dysthymic disorder,Instead of being the most like ADHD. On the other hand, people with SCT do not necessarily have to be depressed and, like other ADHD patients, suffer from persistent inattention.

Based on dsm-IV ®, it was very difficult to diagnose ADHD-Pi in anyone with slow cognitive pace. Many SCT symptoms were listed as ADHD diagnostic features in dsm-III ®, but were removed in dsm-IV ®. Using DSM-V ® will help solve this problem by re-involving most of these symptoms. This should make it easier to view someone with a slow cognitive pace as probably ADHD. It seems that an urgent organized intention of a large group of experts in mental health classifies SCT as a different disease, at present, although individual experts argued for it.

Labeling SCT as other conditions may not be the advantage of someone. A person with a slow elementM cognitive pace usually responds positively to ADHD drugs. Methamphetamine is often most recommended because methylphenidate may not provide effective treatment for this subgroup. They may also be effective antidepressants of serotonin and norepinephrine (SNRI) such as duloxetine and venlafaxine because they interact with norepinephrine levels.

Further scientific research can change the way in which SCT is considered to be the future. More information about the connection between these symptoms and depressive disorders could be useful. Another fertile area of ​​study could be a comparison of psychosocial differences identified by ADHD subgroups. Genetic booking Pinapipting Causes of SCT and its relation to other conditions can answer many questions about this group of symptoms.